GNRO — Geneuro SA Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- €1.02m
- €6.13m
Annual cashflow statement for Geneuro SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.46 | -8.96 | -6.82 | -12.2 | -14.8 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.57 | 1.88 | 0.217 | 0.731 | 0.367 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.36 | -0.453 | -0.47 | -1.88 | 3.95 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9.89 | -7.17 | -6.77 | -13.1 | -10.1 |
| Capital Expenditures | -0.05 | -0.023 | -0.044 | -0.057 | -0.025 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.004 | 0.001 | 0 | 0.007 | 0.076 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.046 | -0.023 | -0.044 | -0.05 | 0.051 |
| Financing Cash Flow Items | -0.249 | -0.275 | -0.046 | -0.031 | -0.035 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.94 | 8.15 | 5.38 | 13.1 | 6.32 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.03 | 0.911 | -1.36 | 0.114 | -3.77 |